Latest AI and machine learning research in other cancers for healthcare professionals.
Photodynamic Diagnosis (PDD) is a non-invasive imaging technique. It relies on a photosensitizer that, when activated by a specific light source, causes metabolically active tissues like tumors to emit visible red fluorescence. PDD offers high sensitivity, high specificity, and real-time visualization. This article reviews advances in the use of PDD for common cutaneous tumors, including Keratinoc...
Rare cells, despite constituting only a small fraction of the population, play a critical role in health and disease. For instance, a minor subset of cancer cells can drive tumor initiation and progression. However, detecting and analyzing rare cells remain challenging due to their low abundance and the need for high-precision identification methods. Microfluidic impedance-based flow cytometry (μI...
The integration of artificial intelligence (AI) into breast cancer management presents transformative potential for both diagnosis and treatment plann...
Ki-67 expression, a critical biomarker for tumor aggressiveness and proliferation in invasive breast cancer, is traditionally assessed via invasive bi...
Retroperitoneal leiomyosarcoma (RLS) is a rare and aggressive subtype of soft tissue sarcoma with limited population-level evidence guiding surgical d...
Dynamic contrast-enhanced (DCE) breast MRI is a highly sensitive modality for detecting breast cancer, but its limited specificity often leads to fals...
BACKGROUND: Accurate detection of lymph node metastasis is crucial for precise tumour staging and treatment planning. Conventional pathological examin...
OBJECTIVE: Pheochromocytoma and paraganglioma (PPGL) have high genetic predisposition rates. In this multicenter study, we aimed to identify risk-modu...
OBJECTIVES: To evaluate the diagnostic value of a machine learning (ML) model based on multi-modal ultrasound features in differentiating benign from ...
Glioblastoma (GB), the most aggressive primary brain tumor, is characterized by profound inter- and intratumoral heterogeneity and a highly immunosupp...
Preoperatively distinguishing follicular thyroid carcinoma (FTC) from follicular thyroid adenoma (FTA) remains a significant clinical challenge. Curre...
BACKGROUND: Artificial intelligence-based radiomic approaches have been shown to accurately evaluate indeterminate pulmonary nodules. With the expansi...
BACKGROUND: Lentigo maligna (LM) and lentigo maligna melanoma (LMM) are difficult to manage because of their subclinical extension and ill-defined mar...
Chimeric antigen receptor (CAR) T-cell therapy has transformed the management of hematologic malignancies, achieving high remission rates in relapsed ...
Therapeutic resistance remains the principal barrier to durable clinical benefit in oncology, particularly in oncogene-driven malignancies and immune-...
Time-of-flight (ToF) in PET improves image quality by enhancing the signal-to-noise ratio, and recent deep learning (DL)-based ToF (DL-ToF) methods fu...
BACKGROUND: Sinonasal inverted papilloma(SNIP) is a benign tumor with a potential of malignant transformation but has a certain recurrence. OBJECTIVES...
BACKGROUND AND PURPOSE: The telomerase reverse transcriptase (TERT) gene promoter mutation is a crucial factor for identifying an isocitrate dehydroge...
Breast cancer diagnosis from histopathological images remains a critical yet challenging task due to staining variability, magnification differences, ...
Prostate cancer exhibits complex transcriptional heterogeneity that underlies disease progression and therapeutic resistance. We developed an integrat...